company background image
CMP logo

Compumedics CHIA:CMP Stock Report

Last Price

AU$0.28

Market Cap

AU$49.6m

7D

3.7%

1Y

86.7%

Updated

26 Mar, 2024

Data

Company Financials

CMP Stock Overview

Compumedics Limited engages in the research, development, manufacturing, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the Americas, Europe, and the Middle East.

CMP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Compumedics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Compumedics
Historical stock prices
Current Share PriceAU$0.28
52 Week HighAU$0.44
52 Week LowAU$0.14
Beta1.15
1 Month Change-9.68%
3 Month Change-5.08%
1 Year Change86.67%
3 Year Change-35.63%
5 Year Change-36.36%
Change since IPO154.55%

Recent News & Updates

Recent updates

Shareholder Returns

CMPAU Medical EquipmentAU Market
7D3.7%1.0%1.7%
1Y86.7%26.8%12.9%

Return vs Industry: CMP exceeded the Australian Medical Equipment industry which returned 26.8% over the past year.

Return vs Market: CMP exceeded the Australian Market which returned 12.9% over the past year.

Price Volatility

Is CMP's price volatile compared to industry and market?
CMP volatility
CMP Average Weekly Movementn/a
Medical Equipment Industry Average Movement11.3%
Market Average Movement8.8%
10% most volatile stocks in AU Market17.3%
10% least volatile stocks in AU Market3.2%

Stable Share Price: CMP's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine CMP's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987135David Burtonhttps://www.compumedics.com.au

Compumedics Limited engages in the research, development, manufacturing, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Okti; Grael PSG; Grael DC; Falcon HST; Somté, an investigative tool; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, an portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device.

Compumedics Limited Fundamentals Summary

How do Compumedics's earnings and revenue compare to its market cap?
CMP fundamental statistics
Market capAU$49.61m
Earnings (TTM)AU$1.23m
Revenue (TTM)AU$50.13m

41.0x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CMP income statement (TTM)
RevenueAU$50.13m
Cost of RevenueAU$23.05m
Gross ProfitAU$27.08m
Other ExpensesAU$25.85m
EarningsAU$1.23m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.007
Gross Margin54.02%
Net Profit Margin2.46%
Debt/Equity Ratio41.9%

How did CMP perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.